Clinical policy: puberty suppressing hormones

Document first published:
Page updated:
Topic:
Publication type:

Puberty suppressing hormones (PSH) are not available as a routine commissioning treatment option for treatment of children and young people who have gender incongruence/gender dysphoria.

These documents may not be fully accessible to all users. If you require the information in a different format please email england.scengagement@nhs.net.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.

Summary

Published 12 March 2024.